A relation between osteoclastogenesis inhibition and membrane-type estrogen receptor GPR30.

about

A relation between osteoclastogenesis inhibition and membrane-type estrogen receptor GPR30.

Item

http://www.wikidata.org/entity/Q41682522

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A relation between osteoclasto ...... -type estrogen receptor GPR30.

@en

type

Item

label

A relation between osteoclasto ...... -type estrogen receptor GPR30.

@en

prefLabel

A relation between osteoclasto ...... -type estrogen receptor GPR30.

@en

P1476

A relation between osteoclasto ...... -type estrogen receptor GPR30.

@en

P2093

Kazuo Tomita

http://www.w3.org/2001/XMLSchema#string

Masaaki Masuhara

http://www.w3.org/2001/XMLSchema#string

Minami Furukawa

http://www.w3.org/2001/XMLSchema#string

Shouichi Miyawaki

http://www.w3.org/2001/XMLSchema#string

Takao Tsukahara

http://www.w3.org/2001/XMLSchema#string

Tomoaki Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

Protective protein/cathepsin A down-regulates osteoclastogenesis by associating with and degrading NF-kappaB p50/p65.

Flavonoids and age-related disease: risk, benefits and critical windows.

GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice.

Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.

The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells.

The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor.

P304

389-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBREP.2016.10.013

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28955981

http://www.w3.org/2001/XMLSchema#string

P932

5614543

http://www.w3.org/2001/XMLSchema#string